$GHDX Recent Headlines 4 stocks with charts po
Post# of 74540
4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Genomic Health up 15% on business update, earnings 10:52 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Stocks to watch Tuesday: Kenexa, Coinstar, ViaSat 7:51 a.m. Feb. 7, 2012 - MarketWatch
Biotech analysts lukewarm on diagnostic stocks 4:16 p.m. Sept. 29, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:01 p.m. Nov. 9, 2010 - MarketWatch
Genomic Health soars as drug indexes ease 12:14 p.m. Nov. 9, 2010 - Val Brickates Kennedy
Genomic Health rockets as drug indexes ease 11:14 a.m. Nov. 9, 2010 - Val Brickates Kennedy
Setting up to retest the 2008 lows 9:27 a.m. Sept. 11, 2008 - Michael Ashbaugh
Genomic Health up 4.4% at $17.48 9:40 a.m. March 27, 2007 - Tomi Kilgore
Genomic Health upped to outperform at Piper Jaffray 7:36 a.m. March 27, 2007 - Tomi Kilgore
Updates, advisories and surprises 11:01 p.m. Feb. 7, 2007 - MarketWatch
Wednesday's biggest stock gainers and decliners 7:26 p.m. Feb. 7, 2007 - Michael Baron
Genomic Health shares fall as loss widens in fourth quarter 11:32 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares fall on Q4 results 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares dwon 7.9% at $19.79 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Wednesday's biggest stock gainers and decliners 7:00 p.m. Jan. 17, 2007 - Michael Baron
Drug stocks rise, but Isis slides on note offering 5:35 p.m. Jan. 17, 2007 - Val Brickates Kennedy
Genomic Health down 9.9% at $21.33 10:48 a.m. Jan. 17, 2007 - Tomi Kilgore
Genomic Health cut to equal weight at Lehman Bros. 10:26 a.m. Jan. 17, 2007 - Tomi Kilgore
Wednesday's biggest stock gainers and decliners 5:56 p.m. Jan. 10, 2007 - Michael Baron
Balanced View on Genomic Health - Analyst Blog 3:20 p.m. April 8, 2014 - Zacks.com
Genomic Health, Inc. (GHDX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 4, 2014 - Zacks.com
Bear of the Day: Genomic Health (GHDX) - Bear of the Day 4:09 a.m. April 3, 2014 - Zacks.com
Genomic Health Unveils Oncotype DX Data - Analyst Blog 6:15 p.m. March 20, 2014 - Zacks.com
Foundation Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
Fountain Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
10-K: GENOMIC HEALTH INC 4:44 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zacks Rank #5 Additions for Thursday - Tale of the Tape 10:30 a.m. Feb. 27, 2014 - Zacks.com
5 Biotechnology Stocks to Sell Now 3:15 a.m. Feb. 19, 2014 - InvestorPlace.com
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 9:45 a.m. Feb. 13, 2014 - Zacks.com
Weakness seen in Genomic Health (GHDX): Stock Tumbles 9.0% - Tale of the Tape 9:43 a.m. Feb. 6, 2014 - Zacks.com
Q4 Loss Narrower Than Expected at Genomic, Revs Up Y/Y - Analyst Blog 11:30 a.m. Feb. 5, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is Below Expectations 10:15 a.m. Feb. 5, 2014 - benzinga.com
Genomic Health Management Discusses Q4 2013 Results - Earnings Call Transcript 9:10 p.m. Feb. 4, 2014 - Seeking Alpha
Q4 2013 Genomic Health Inc Earnings Conference call (Webcast) 5:25 p.m. Feb. 4, 2014 - Seeking Alpha
A New Approach to Prostate Cancer 8:12 p.m. Jan. 13, 2014 - The Wall Street Journal Interactive Edition
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 10:21 a.m. Jan. 10, 2014 - Zacks.com
InterMune (ITMN) Jumps: Stock Rises 9.5% - Tale of the Tape 9:57 a.m. Jan. 10, 2014 - Zacks.com
Agenus (AGEN) Jumps: Stock Adds 8.8% in Session - Tale of the Tape 9:51 a.m. Jan. 10, 2014 - Zacks.com
Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 10:21 a.m. Jan. 9, 2014 - Zacks.com
Genomic Health Announces Presentation of New Data Further Supporting Use of Oncotype DX® in Europe 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Genomic Health Announces Year-End 2013 Financial Results, Provides 2014 Financial Outlook 5:01 p.m. Feb. 4, 2014 - PR Newswire - PRF
Genomic Health Announces Results of Oncotype DX® Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium 9:00 a.m. Jan. 29, 2014 - PR Newswire - PRF
Genomic Health to Announce Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on Tuesday, February 4, 2014 9:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients 9:00 a.m. Jan. 7, 2014 - PR Newswire
Genomic Health Announces Presentation at J.P. Morgan Healthcare Conference 5:00 p.m. Jan. 6, 2014 - PR Newswire
Healthcare Companies Announce Study Results, Acquisitions and Company Updates - Research Report on Sirona Dental Systems, Ligand Pharmaceuticals, Genomic Health, Unilife, and Sykes 9:00 a.m. Dec. 24, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 9:00 a.m. Dec. 16, 2013 - PR Newswire
Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium 9:35 a.m. Dec. 14, 2013 - PR Newswire
Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With a Reliable, Fast, Affordable Option for Patients 9:30 a.m. Dec. 11, 2013 - BusinessWire
Invitae Completes $40 Million Series E Financing 10:00 a.m. Dec. 10, 2013 - BusinessWire
Genomic Health Announces Presentation of Oncotype DX® Studies at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) 9:00 a.m. Dec. 4, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - BusinessWire
Genomic Health Announces Publication of Oncotype DX® Prostate Cancer Test Analytical Validation Study 9:00 a.m. Nov. 22, 2013 - PR Newswire
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development 9:00 a.m. Nov. 19, 2013 - PR Newswire
Company Statements, Study Results, Stock Movements, Awards and Stock Splits - Research Report on WebMD, Cerner, Waters, Medidata and Genomic Health 9:00 a.m. Nov. 18, 2013 - PR Newswire
Genomic Health Announces Colon Cancer Publication in Journal of Clinical Oncology Supporting Wider Oncotype DX® Utilization 9:00 a.m. Nov. 13, 2013 - PR Newswire
Companies in the Healthcare Sector Report Financial Results, and Scheduled Conference calls - Research Report on OXiGENE, BioTelemetry, Abiomed, Emeritus, and Genomic Health 9:00 a.m. Nov. 11, 2013 - PR Newswire
Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress 5:01 p.m. Nov. 5, 2013 - PR Newswire